Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Trudie Lang is Highly Commended for 'Enabling Research in Low-Income Settings During Disease Outbreaks: Implementing, Learning and Preparing' in the Building Capacity category of the University Vice-Chancellor Innovation Awards 2020.

Trudie Lang and the Vice-Chancellor's Innovation Awards logo

Congratulations to Professor Trudie Lang who has been Highly Commended in the Building Capacity category of the Vice-Chancellor Innovation Awards 2020 for her work on Enabling Research in Low-Income Settings During Disease Outbreaks: Implementing, Learning and Preparing.

The Vice-Chancellor Innovation Awards celebrate research-led innovation that is having societal or economic impact. Building on the awards two years ago a new category of Policy Engagement has been added to those for TeamworkBuilding CapacityInspiring Leadership, and Early Career Innovator.

Winners and Highly Commended entries were selected by the Vice-Chancellor’s Innovation Awards panel chaired by Professor Chas Bountra, Pro-Vice-Chancellor for Innovation, and comprising academics from each of the four Divisions and Professional Services staff who support impact and innovation across the collegiate University

You can find out more about the Awards and all of 2020’s Winners and Highly Commended entries on the Vice-Chancellor’s Innovation Awards pages.

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Peter Macharia wins RSTMH Emerging Leader Award

Peter Macharia is a spatial epidemiologist and a postdoc interested in disease mapping, healthcare access and mapping population vulnerabilities at KEMRI Wellcome. He received the RSTMH 2021 Emerging Leader Award, which recognises significant contributions in leadership, mentoring and capacity building in those who are early in their careers.

Lack of evidence is key barrier to using portable devices to detect poor quality medicines

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.

RECOVERY Trial paper on dexamethasone wins BMJ’s 2021 UK Research Paper of the Year Award

A RECOVERY Collaborative Group paper has been announced as the 2021 winner of The British Medical Journal’s prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare. The paper, “Dexamethasone in Hospitalized Patients with Covid-19”, published in the New England Journal of Medicine, described the discovery in June 2020 of the world’s first effective, readily available treatment for COVID-19 – the inexpensive steroid, dexamethasone.

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

There are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.